Author Question: A 72-year-old woman is being treated on a medical unit 1 week after experiencing an ischemic stroke. ... (Read 76 times)

123654777

  • Hero Member
  • *****
  • Posts: 585
A 72-year-old woman is being treated on a medical unit 1 week after experiencing an ischemic stroke. The effects of the woman's stroke include slurred, partially intelligible speech.
 
  However, the patient's comprehension of spoken language remains intact. The nurse should expect to read documentation in the patient's chart of:
  A) Dysarthria
  B) Aphasia
  C) Dysphasia
  D) Apraxia

Question 2

A community health nurse is conducting a workshop for unlicensed care providers who work in a chain of long-term care facilities. The nurse is teaching the participants about the signs and symptoms of stroke.
 
  What signs and symptoms should the nurse identify? Select all that apply.
  A) Epistaxis (nosebleed)
  B) Confusion
  C) Sudden numbness
  D) Sudden ear pain
  E) Visual disturbances



jordangronback

  • Sr. Member
  • ****
  • Posts: 339
Answer to Question 1

A

Answer to Question 2

B, C, E



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Children with strabismus (crossed eyes) can be treated. They are not able to outgrow this condition on their own, but with help, it can be more easily corrected at a younger age. It is important for infants to have eye examinations as early as possible in their development and then another at age 2 years.

Did you know?

A headache when you wake up in the morning is indicative of sinusitis. Other symptoms of sinusitis can include fever, weakness, tiredness, a cough that may be more severe at night, and a runny nose or nasal congestion.

Did you know?

When blood is deoxygenated and flowing back to the heart through the veins, it is dark reddish-blue in color. Blood in the arteries that is oxygenated and flowing out to the body is bright red. Whereas arterial blood comes out in spurts, venous blood flows.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

Multiple experimental evidences have confirmed that at the molecular level, cancer is caused by lesions in cellular DNA.

For a complete list of videos, visit our video library